Association between human papillomavirus infection and cytological abnormalities during early follow-up of invasive cervical cancer

Journal of Medical Virology
Ana Emília Borges de AzevedoAlbino Verçosa de Magalhães

Abstract

Considering the limitations of cytology for detection of residual cervical cancer after radiotherapy, the aim of this study was to evaluate the frequency and viral load of high-risk HPV in cervical and vaginal samples during the early follow-up of patients treated for invasive cervical cancer and correlate the results with cytological examination. Conventional cytology and hybrid capture test were performed on cervical and vaginal samples of 52 women with invasive cervical carcinoma 3 months after therapy. High-risk HPV was detected in 46.1% of the samples and the median and the range of the ratio relative light unit (RLU)/cutoff (CO) (estimated viral load) in positive samples was 1.71 (1-2120.03). No significant difference was observed in viral frequency and in median of the ratio RLU/CO between samples of patients at different stages (I-III) and between cervical samples, from patients treated by exclusive radiotherapy with or without chemotherapy, and vaginal samples, from patients who underwent to hysterectomy and radiotherapy with or without chemotherapy. Cytological abnormalities were more frequent significantly in samples with HPV than in samples without HPV. The viral load was also higher significantly in samples with cy...Continue Reading

References

Aug 1, 1995·Gynecologic Oncology·W T Creasman
Aug 16, 2001·Journal of Medical Virology·G TerryA Lorincz
Apr 17, 2002·International Journal of Radiation Oncology, Biology, Physics·Yoko HarimaTakeo Ohnishi
Apr 23, 2002·JAMA : the Journal of the American Medical Association·Diane SolomonUNKNOWN Bethesda 2001 Workshop
Dec 14, 2004·American Journal of Obstetrics and Gynecology·Yutaka NagaiKoji Kanazawa
Nov 24, 2005·Cytopathology : Official Journal of the British Society for Clinical Cytology·N SinghM E B Powell
Jun 29, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R K SinghC K Panda
Sep 5, 2006·Vaccine·D Maxwell Parkin, Freddie Bray
Oct 13, 2007·BMJ : British Medical Journal·Patrick Petignat, Michel Roy
Oct 16, 2008·American Journal of Clinical Pathology·Gian Franco Zannoni, Valerio Gaetano Vellone
Jul 10, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C Haie-MederUNKNOWN ESMO Guidelines Working Group
Jun 30, 2009·Gynecologic Oncology·Laurie ElitUNKNOWN Gynecology Cancer Disease Site Group
Mar 6, 2010·Oncology Reports·Gianna BadaraccoAldo Venuti
Jun 23, 2010·Current Oncology·L ElitUNKNOWN members of the Gynecology Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-Based Care
Nov 11, 2010·International Journal of Cancer. Journal International Du Cancer·Yong Jung SongSang-Yoon Park
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin

❮ Previous
Next ❯

Citations

Dec 18, 2013·Indian Journal of Sexually Transmitted Diseases and AIDS·Livia Bravo MaiaPaulo Gonçalves de Oliveira
May 28, 2014·Revista Da Sociedade Brasileira De Medicina Tropical·Livia Bravo MaiaPaulo Gonçalves de Oliveira
Sep 8, 2015·HIV Medicine·L B MaiaP G de Oliveira

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.